(2023)
Serum metabolome signatures characterizing co-infection of Plasmodium falciparum and HBV in pregnant women.
Diseases 11(3),
94.
Publications
(2023)
Non-patient-related SARS-CoV-2 exposure from colleagues and household members poses the highest infection risk for hospital employees in a German university hospital: follow-up of the prospective Co-HCW seroprevalence study.
Infection 51(4),
1051-1059.
(2023)
Targeting the host response in sepsis: current approaches and future evidence.
Crit Care 27(1),
478.
(2023)
Simvastatin in critically Ill patients with Covid-19.
N Engl J Med 389(25),
2341-2354.
(2023)
Public health risk communication through the lens of a quarantined community: Insights from a coronavirus hotspot in Germany.
PLoS One 18(10),
e0292248.
(2023)
What's new in intensive care: disease tolerance.
Intensive Care Med 49(10),
1235-1237.
(2023)
Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection-the CoNAN long-term study.
Front Immunol 13,
1095129.
(2022)
Persistent T-cell reactivity in a seronegative patient after SARS-CoV-2 infection and one vaccination.
Vaccines (Basel) 10(1),
114.
(2022)
Development of a new antigen-based microarray platform for screening and detection of human IgG antibodies against SARS-CoV-2.
Sci Rep 12(1),
8067.
(2022)
Complicated and uncomplicated S. aureus bacteraemia: an international Delphi survey among infectious diseases experts on definitions and treatment.
Clin Microbiol Infect 28(7),
1026.e7.